VBCG
CVS icon

Valley Brook Capital Group’s CVS Health CVS Stock Holding History

Valley Brook Capital Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,843
Closed -$386K – 114
2024
Q1 		$386K Buy
4,843
+72
+2% +$5.5K 0.31% 78
2023
Q4 		$377K Sell
4,771
-350
-7% -$24.9K 0.33% 74
2023
Q3 		$358K Sell
5,121
-3,235
-39% -$229K 0.35% 68
2023
Q2 		$578K Sell
8,356
-863
-9% -$61.4K 0.53% 57
2023
Q1 		$685K Sell
9,219
-19
-0.2% -$1.59K 0.63% 51
2022
Q4 		$861K Buy
9,238
+161
+2% +$15.5K 0.83% 37
2022
Q3 		$865K Buy
9,077
+175
+2% +$17.3K 0.94% 34
2022
Q2 		$824K Hold
8,902
– – 0.85% 35
2022
Q1 		$900K Buy
8,902
+461
+5% +$48.4K 0.78% 40
2021
Q4 		$870K Hold
8,441
– – 0.75% 39
2021
Q3 		$716K Sell
8,441
-450
-5% -$37.7K 0.71% 43
2021
Q2 		$741K Buy
8,891
+125
+1% +$10.2K 0.71% 45
2021
Q1 		$659K Buy
8,766
+600
+7% +$43.7K 0.6% 43
2020
Q4 		$557K Buy
+8,166
New +$531K 0.55% 44

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Valley Brook Capital Group's CVS Position: Q2 2024 in Review

Valley Brook Capital Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,843 shares — an estimated $386K sold.

Valley Brook Capital Group first reported a position in CVS in Q4 2020 and held it in 14 quarters. The position peaked at $900K in Q1 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Valley Brook Capital Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Valley Brook Capital Group sold 4,843 CVS Health shares in Q2 2024, an estimated $386K.
  • Valley Brook Capital Group first reported a position in CVS Health in Q4 2020 and held it in 14 quarters.
  • Valley Brook Capital Group's CVS Health position peaked at $900K in Q1 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Valley Brook Capital Group's 13F filing for Q2 2024, filed 26 Jul 2024.